Research Use Only

    This site is an independent educational resource for research compounds. We do not sell, distribute, or endorse human consumption of any compound. By entering, you confirm you are 21 years of age or older and agree to our Terms & Privacy Policy.

    ๐Ÿ”ฌ 93K+ researchers trust BodyHackGuide โ€” Join r/BodyHackGuide
    LL-37 molecular structure

    LL-37

    Immune & InflammationPhase 2

    LL-37 is the only known human cathelicidin antimicrobial peptide, derived from the C-terminus of the human CAP18 protein. It is produced by epithelial cells, neutrophils, macrophages, and NK cells in response to infection and inflammation.

    Overview

    Key Takeaways

    • โ†’Broad-spectrum antimicrobial activity
    • โ†’Wound healing acceleration
    • โ†’Biofilm disruption

    At A Glance

    LL-37 disrupts bacterial cell membranes through electrostatic interactions with anionic phospholipids, forming pores that lead to membrane disintegration โ€” effective against gram-positive, gram-negative bacteria, and fungi. It also modulates innate immunity by acting as a chemokine for neutrophil and monocyte recruitment, activating Toll-like receptor signaling, and inducing angiogenesis. Anti-cancer activity may involve direct tumor cell membrane disruption and immune activation.

    LL-37 disrupts bacterial cell membranes through electrostatic interactions with anionic phospholipids, forming pores that lead to membrane disintegration โ€” effective against gram-positive, gram-negative bacteria, and fungi. It also modulates innate immunity by acting as a chemokine for neutrophil and monocyte recruitment, activating Toll-like receptor signaling, and inducing angiogenesis. Anti-cancer activity may involve direct tumor cell membrane disruption and immune activation.

    Overview

    LL-37 is the only known human cathelicidin antimicrobial peptide, derived from the C-terminus of the human CAP18 protein. It is produced by epithelial cells, neutrophils, macrophages, and NK cells in response to infection and inflammation. Research spans antimicrobial applications, wound healing, immunomodulation, and potential anti-cancer properties.

    Potential Benefits

    Broad-spectrum antimicrobial activityWound healing accelerationBiofilm disruptionImmune system modulationAnti-inflammatory effectsGut barrier support

    Potential Research Fields

    Chronic infectionsWound healingCystic fibrosisChronic sinusitisSkin conditionsCancer

    Chemical Information

    IUPAC Name

    Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys... (37 amino acid sequence)

    CAS Number

    154947-66-7

    Molecular Formula

    C205H340N60O53S

    Molecular Mass

    4493.4 g/mol

    Dosing & Protocols

    Unlock Dosing Protocols

    Create a free account to:

    • View beginner, intermediate & advanced protocols
    • See weight-based dosing calculations
    • Access cycle length & frequency data

    Join 2,800+ researchers

    Research

    Unlock Research Data

    Create a free account to:

    • Browse PubMed study summaries
    • See clinical trial phases & results
    • Access mechanism of action details

    Join 2,800+ researchers

    Interactions

    Interaction Matrix

    Contraindications

    Known autoimmune conditions (may exacerbate immune response). Pregnancy or breastfeeding. Active systemic infection requiring specific antimicrobials.

    Research Disclaimer

    This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds.

    No listings found for LL-37.

    Get LL-37 Price Drop Alerts

    Set a target price and we'll notify you when any vendor drops below it.

    Research Score

    100

    3013 PubMed studies

    Quality Indicators

    Data Completeness

    75%
    Description
    Mechanism of Action
    Chemical Data
    Dosing Protocols
    Safety Profile
    PubMed Studies
    Interactions
    Vendor Listings

    Research Credibility

    3013PubMed studies

    Well-researched compound

    Quick Facts

    Molecular Weight

    4493.4 g/mol

    CAS Number

    154947-66-7

    Trial Phase

    Phase 2

    Safety Profile

    Moderate Risk

    Common Side Effects

    • โ€ข Injection site pain and inflammation
    • โ€ข Transient fever (immune activation)
    • โ€ข Nausea

    Stop Use If

    • Sepsis or uncontrolled systemic infection
    • Autoimmune conditions โ€” may exacerbate

    Research Disclaimer

    This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use.

    Frequently Asked Questions

    What is LL-37 used for in research?

    LL-37 is the only known human cathelicidin antimicrobial peptide, derived from the C-terminus of the human CAP18 protein. It is produced by epithelial cells, neutrophils, macrophages, and NK cells in response to infection and inflammation. Research spans antimicrobial applications, wound healing, immunomodulation, and potential anti-cancer properties.

    What forms does LL-37 come in?

    LL-37 is available in vials, capsules, and sprays forms.

    How much does LL-37 cost?

    Pricing varies by vendor and form.

    How do I compare LL-37 vendors?

    Compare prices, payment methods, shipping, and COA scores across 0 vendors.

    Research Tools

    Related Compounds

    View All

    Get Bloodwork Done Right

    Comprehensive panels from Anabolic Insights โ€” use code CHONCH for a discount on your first order.